内皮一氧化氮合酶增强剂用于保护人胸廓内动脉内皮功能免受非对称性二甲基精氨酸诱导的损伤

Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery
2012-09-20 14:58点击:52次发表评论
作者:Xuan, C.a, Chang, F.-J.b, Liu, X.-C.a, Bai, X.-Y.a
机构: 南开大学医学院泰达国际心血管病医院
期刊: J THORAC CARDIOV SUR2012年9月3期144卷

He, G.-W.; TEDA International Cardiovascular Hospital, Medical College, Nankai University, No. 61, The 3rd, TEDA, Tianjin, 300457, China; email:heguowei@nankai.edu.cn

Objectives: Endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine is a cardiovascular risk factor that is elevated in patients with coronary artery disease. We hypothesized that novel endothelial nitric oxide synthase enhancer AVE3085 might improve the endothelial function altered by asymmetric dimethylarginine in the human internal thoracic artery. Methods: Cumulative concentration-relaxation curves to acetylcholine (-11 to -5 log mol/L) were established in left internal thoracic artery rings (n = 65) from 27 patients undergoing coronary artery bypass grafting in precontraction induced by U46619 (-8 log mol/L) in the absence or presence of asymmetric dimethylarginine (100 μmol/L) or AVE3085 (30 μmol/L). Protein expressions of endothelial nitric oxide synthase and levels of superoxide anion production were detected. Results: Maximal relaxation induced by acetylcholine was significantly attenuated by asymmetric dimethylarginine (12.7% ± 2.3% vs 35.3% ± 5.0% in control; P < .05) and significantly restored by AVE3085 (23.4% ± 2.8%; P < .05). AVE3085 also markedly restored endothelial nitric oxide synthase expression (0.29 ± 0.008; P = .012) reduced by asymmetric dimethylarginine (0.05 ± 0.04 vs 0.36 ± 0.03 in control; P = .014). Increased superoxide anion production by asymmetric dimethylarginine (2.97 ± 0.25 vs 0.51 ± 0.10 relative light units/[s/mg] in control; P < .05) was inhibited by AVE3805 (0.62 ± 0.104 relative light units/[s/mg]; P < .05). Conclusions: AVE3085 may restore endothelium-dependent relaxation reduced by asymmetric dimethylarginine through upregulation of endothelial nitric oxide synthase expression and inhibition of production of superoxide anion in human internal thoracic artery. These findings provide new insights into endothelial protection of coronary bypass grafting vessels to improve long-term patency of grafts. Copyright © 2012 by The American Association for Thoracic Surgery.

TEDA International Cardiovascular Hospital, Medical College, Nankai University, No. 61, The 3rd, TEDA, Tianjin, 300457, China

通讯作者:He, G.-W.; TEDA International Cardiovascular Hospital, Medical College, Nankai University, No. 61, The 3rd, TEDA, Tianjin, 300457, China; email:heguowei@nankai.edu.cn
学科代码:呼吸病学   关键词:内皮一氧化氮合酶增强剂用于保护人胸廓内动脉内皮功能免受非对称
来源: Scopus
Scopus介绍:Scopus 于2004年11月正式推出,是目前全球规模最大的文摘和引文数据库。Scopus涵盖了由5000多家出版商出版发行的科技、医学和社会科学方面的18,000多种期刊,其中同行评审期刊16,500多种。相对于其他单一的文摘索引数据库而言,Scopus的内容更加全面,学科更加广泛,特别是在获取欧洲及亚太地区的文献方面,用户可检索出更多的文献数量。通过Scopus,用户可以检索到1823年以来的近4000万条摘要和题录信息,以及1996年以来所引用的参考文献。数据每日更新。 马上访问Scopus网站http://www.scopus.com/
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录